Single agent palliative chemotherapy for end-stage Hodgkin's disease.
D000293:Adolescent; D000328:Adult; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008130:Lomustine / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009607:Nitrosourea Compounds / Q000627:therapeutic use*; D010166:Palliative Care; D012008:Recurrence; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced
D009607:Nitrosourea Compounds; D008130:Lomustine